Literature DB >> 1394155

Familial aggregation of hematopoietic malignancies and risk of non-Hodgkin's lymphoma.

M S Linet1, L M Pottern.   

Abstract

Examination of risk factors that may be responsible for the increasing incidence of non-Hodgkin's lymphoma (NHL) over the past few decades would be incomplete without considering familial aggregation of hematolymphoproliferative neoplasms and the relative contributions of heredity and environment to the etiology of NHL. Reports of families with two or more NHL cases and sometimes additional members affected by other hematopoietic malignancies (multiple-case families) are summarized, as are findings from surveys and quantitative risk estimates from population-based studies of familial aggregation. The notable occurrence of various immunological abnormalities among multiple-case family members with and without NHL or related neoplasms is underscored, as is the diversity of types of other lymphoproliferative and hematopoietic malignancies among close relatives in these families. Preliminary evidence suggesting that multiple-case families may be more susceptible to certain environmental exposures is presented. An international registry of such families (particularly those identified in population-based studies) is proposed to clarify the interrelationship of genetic, familial, and environmental factors in the etiology of NHL.

Entities:  

Mesh:

Year:  1992        PMID: 1394155

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph).

Authors:  Sophia S Wang; Susan L Slager; Paul Brennan; Elizabeth A Holly; Silvia De Sanjose; Leslie Bernstein; Paolo Boffetta; James R Cerhan; Marc Maynadie; John J Spinelli; Brian C H Chiu; Pier Luigi Cocco; Fiona Mensah; Yawei Zhang; Alexandra Nieters; Luigino Dal Maso; Paige M Bracci; Adele Seniori Costantini; Paolo Vineis; Richard K Severson; Eve Roman; Wendy Cozen; Dennis Weisenburger; Scott Davis; Silvia Franceschi; Carlo La Vecchia; Lenka Foretova; Nikolaus Becker; Anthony Staines; Martine Vornanen; Tongzhang Zheng; Patricia Hartge
Journal:  Blood       Date:  2006-12-21       Impact factor: 22.113

2.  The influence of parental age and gender on anticipation in familial B-cell malignancies.

Authors:  Doru T Alexandrescu; Peter H Wiernik
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

3.  Familial pancreatic lymphoma.

Authors:  J A James; D W Milligan; G J Morgan; J Crocker
Journal:  J Clin Pathol       Date:  1998-01       Impact factor: 3.411

Review 4.  Primary pancreatic lymphoma: a case report, literature review, and proposal for nomenclature.

Authors:  J R Salvatore; B Cooper; I Shah; T Kummet
Journal:  Med Oncol       Date:  2000-08       Impact factor: 3.064

5.  Risk of lymphoproliferative malignancy in celiac patients with a family history of lymphoproliferative malignancy.

Authors:  Jonas F Ludvigsson; Benjamin Lebwohl; Alberto Rubio-Tapia; Joseph A Murray; Peter H R Green; Anders Ekbom
Journal:  J Gastroenterol       Date:  2013-02-27       Impact factor: 7.527

Review 6.  Genetic susceptibility to lymphoma.

Authors:  Christine F Skibola; John D Curry; Alexandra Nieters
Journal:  Haematologica       Date:  2007-07       Impact factor: 9.941

7.  Familial T-cell non-Hodgkin lymphoma caused by biallelic MSH2 mutations.

Authors:  Richard H Scott; Tessa Homfray; Nicola L Huxter; Sally G Mitton; Ruth Nash; Mike N Potter; Donna Lancaster; Nazneen Rahman
Journal:  J Med Genet       Date:  2007-07       Impact factor: 6.318

Review 8.  The genetics of familial lymphomas.

Authors:  Rina Siddiqui; Kenan Onel; Flavia Facio; Kenneth Offit
Journal:  Curr Oncol Rep       Date:  2004-09       Impact factor: 5.075

9.  Familial Aggregation of Non-Hodgkin's Lymphoma (NHL). A Case Report.

Authors:  Sandra Scm Loves; Lieuwe de Haan; Simon Mgj Daenen
Journal:  Hered Cancer Clin Pract       Date:  2006-08-15       Impact factor: 2.857

10.  Clustering of cancer among families of cases with Hodgkin Lymphoma (HL), Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL), Soft Tissue Sarcoma (STS) and control subjects.

Authors:  Helen H McDuffie; Punam Pahwa; Chandima P Karunanayake; John J Spinelli; James A Dosman
Journal:  BMC Cancer       Date:  2009-02-27       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.